Deutsche Bank AG Has $3.42 Million Holdings in Prestige Consumer Healthcare Inc. $PBH

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Deutsche Bank AG trimmed its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 9.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,830 shares of the company's stock after selling 3,979 shares during the quarter. Deutsche Bank AG owned approximately 0.08% of Prestige Consumer Healthcare worth $3,424,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in PBH. Kayne Anderson Rudnick Investment Management LLC acquired a new stake in shares of Prestige Consumer Healthcare during the fourth quarter valued at about $84,932,000. BNP Paribas Financial Markets boosted its stake in shares of Prestige Consumer Healthcare by 1,073.3% during the fourth quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock valued at $15,923,000 after purchasing an additional 186,524 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Prestige Consumer Healthcare by 11,580.3% during the first quarter. GAMMA Investing LLC now owns 161,538 shares of the company's stock valued at $13,887,000 after purchasing an additional 160,155 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Prestige Consumer Healthcare during the fourth quarter valued at about $7,778,000. Finally, Congress Asset Management Co. boosted its stake in shares of Prestige Consumer Healthcare by 9.1% during the first quarter. Congress Asset Management Co. now owns 991,580 shares of the company's stock valued at $85,246,000 after purchasing an additional 82,838 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Trading Up 2.0%

Shares of Prestige Consumer Healthcare stock traded up $1.3050 during midday trading on Friday, reaching $66.7550. The company had a trading volume of 542,270 shares, compared to its average volume of 583,477. The stock has a fifty day moving average price of $75.29 and a 200 day moving average price of $81.22. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. The firm has a market cap of $3.29 billion, a PE ratio of 15.67, a P/E/G ratio of 2.11 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.95 and a fifty-two week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). The company had revenue of $249.53 million during the quarter, compared to analyst estimates of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.Prestige Consumer Healthcare's revenue was down 6.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.90 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. On average, equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Royal Bank Of Canada raised Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Canaccord Genuity Group cut their price target on Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Finally, Wall Street Zen lowered Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.